Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

30 March 2017

  • Advanced technology and production transfer deepens companies’ long-standing partnership within diabetes care   
  • Dedicated to advancing new technologies for continuous insulin infusion

READING, UNITED KINGDOM (29 March 2017) – Convatec Group Plc (“Convatec”), a leading global medical products and technologies company, today announced an expansion of its manufacturing technology platform for the insulin pump therapy business at Medtronic. With this expansion, Convatec’s Unomedical subsidiary is increasing its production capabilities to sustain the range of infusion sets and insulin pump therapy solutions offered by the Diabetes Group at Medtronic.

The arrangement further deepens the companies’ long-standing partnership within diabetes care and their shared commitment to meeting the growing demand for insulin pump therapy among people with diabetes. An estimated 700,000 people worldwide, predominantly with type 1 diabetes, depend on insulin pump therapy.1

Convatec’s Unomedical subsidiary develops, produces and supplies to Medtronic a range of disposable infusion sets, including MiniMed® QuickSet®, MiniMed Silhouette®, MiniMed Sure-T® and the MiniMed Mio® family, used in insulin pump therapy. An infusion set is a critical component of an insulin pump system, consisting of a small tube called a cannula, typically inserted under the skin in the abdominal area, which delivers insulin from an insulin pump to the body of a person with diabetes.

“We are excited to expand our long-standing partnership with Medtronic, sharing advanced technologies and complementary competencies to ensure that we can meet the needs of the increasing number of people with diabetes who are depending on insulin pump therapy,” said John M. Lindskog, President, Infusion Devices, Convatec. “Together, we have a great foundation for offering the best solutions for people with diabetes, giving them more control and freedom in their lives.”

“We have a trusted partner in Unomedical with significant manufacturing know-how and a long track record of delivering reliable, high quality consumable components as we continue to expand our insulin pump business around the world,” added Bogdan Madzar, Vice President of R&D and Global Consumables for Diabetes Service and Solutions at Medtronic. “Together, we are advancing innovations that expand the options for people using insulin pumps as we seek to both improve outcomes and satisfy lifestyle needs so that people with diabetes can enjoy greater freedom and better health.”

Since 1997, Unomedical and Medtronic have worked in collaboration to improve the lives of people with diabetes using insulin pump therapy. As the partnership enters its third decade, the two companies are working together to develop the next generation of solutions for continuous insulin infusion

Enquiries

Convatec

Bobby Leach, VP Group Corporate Affairs, Convatec    +44 (0)7770 842 226
Kirsty Law, Director Investor Relations                              +44 (0)7470 909 582

Finsbury

Rebecca Fitchett                                                                     +44 (0)207 251 3801

About Convatec

About Convatec  Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Convatec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

# # #

 

® indicate trademarks of Medtronic MiniMed, Inc.
© 2017 Convatec Inc.
AP-017565-GB

------------------------------------------------
1 Global Insulin Pump Market with Focus on Patch Pumps (2016 – 2020) Daedal Research, March 2016

Download PRESS RELEASE

PDF Download

Press Release

See all

5/13/2022

5/13/2022

Organisation Appointments

Organisation Appointments

Read more

5/13/2022

5/13/2022

FY2017 guidance and third quarter update

FY2017 guidance and third quarter update

Read more

5/13/2022

5/13/2022

Convatec Introduces GentleCath™ Glide and me+™ Continence Care Programme for Intermittent Catheter Users in Europe

Convatec Introduces GentleCath™ Glide and me+™ Continence Care Programme for Intermittent Catheter Users in Europe

Read more

5/13/2022

5/13/2022

Scrip Dividend

Scrip Dividend

Read more

5/13/2022

5/13/2022

Appointment to Executive Committee

Appointment to Executive Committee

Read more

5/13/2022

5/13/2022

Convatec appoints two Non-Executive Directors

Convatec appoints two Non-Executive Directors

Read more

8/3/2017

8/3/2017

Convatec Launches Natura™ Convex Accordion Flange™, Designed to Make Ostomy Pouch Application Easier and More Comfortable

Convatec Launches Natura™ Convex Accordion Flange™, Designed to Make Ostomy Pouch Application Easier and More Comfortable

Read more

5/12/2022

5/12/2022

Convatec Announces 2017 Interim results

Convatec Announces 2017 Interim results

Read more

5/12/2022

5/12/2022

03 August 2017 - Board Changes

03 August 2017 - Board Changes

Read more

5/12/2022

5/12/2022

Convatec Announces Acquisition of Woodbury Holdings

Convatec Announces Acquisition of Woodbury Holdings

Read more

5/13/2022

5/13/2022

Announcement on Board of Directors

Announcement on Board of Directors

Read more

5/12/2022

5/12/2022

Trading Update for the three months ended 31 March 2017

Trading Update for the three months ended 31 March 2017

Read more